Evidence map›Paper›PMID 26892461›Full record

ArticleCardiovascular diabetology2016

Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects.

Helena U Westergren, Sara Svedlund, Remi A Momo, Juuso I Blomster, Karin Wåhlander, Erika Rehnström, Peter J Greasley, Regina Fritsche-Danielson, Jan Oscarsson, Li-Ming Gan

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2019
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Helena U WestergrenDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. helena.westergren@gu.se.
Sara SvedlundDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Sara.svedlund@gu.se.
Remi A MomoAstraZeneca R&D, Gothenburg, Sweden. Remi.momo@astrazeneca.com.
Juuso I BlomsterDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Juuso.blomster@gmail.com.
Karin WåhlanderAstraZeneca R&D, Gothenburg, Sweden. karin.fc.wahlander@telia.com.
Erika RehnströmAstraZeneca R&D, Gothenburg, Sweden. Erika.Rehnstrom@astrazeneca.com.
Peter J GreasleyAstraZeneca R&D, Gothenburg, Sweden. Peter.Greasley@astrazeneca.com.
Regina Fritsche-DanielsonAstraZeneca R&D, Gothenburg, Sweden. Regina.Fritsche-Danielson@astrazeneca.com.
Jan OscarssonAstraZeneca R&D, Gothenburg, Sweden. Jan.oscarsson@astrazeneca.com.
Li-Ming GanDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. li-ming.gan@gu.se.
AstraZeneca (Netherlands) · NLSahlgrenska University Hospital · SEAstraZeneca (Finland) · FIUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with angina-like symptoms without myocardial perfusion scintigram (MPS)-verified abnormality may still be at risk for cardiovascular events. We hypothesized that insulin resistance could play a role in this population even without diagnosed diabetes. We further explored physiological and blood biomarkers, as well as global gene expression patterns that could be closely related to impaired glucose homeostasis to deepen our mechanistic understanding.

methodsA total of 365 non-diabetic patients with suspected myocardial ischemia referred to MPS were enrolled and followed up regarding event-free survival with a median time of 5.1 years. All patients underwent endothelial function assessment by reactive hyperemic index (RHI) using EndoPAT and extensive biomarker analysis. Whole blood global gene expression pathway analysis was performed in a subset of patients.

resultsHomeostasis model assessment of insulin resistance (HOMA-IR) added independent prognostic value in patients without myocardial perfusion defects. In a multivariable analysis, HOMA-IR was inversely associated with low RHI. Furthermore, elevated HOMA-IR was associated with decreased levels of vascular endothelial growth factor D, stem cell factor and endocan as well as to increased level of interleukin-6. Global gene expression pathway analysis of whole blood cells showed that high HOMA-IR and impaired endothelial function were associated with upregulated pro-inflammatory pathways and down-regulated eukaryotic initiation factor-2 pathway.

conclusionsInsulin resistance measured by HOMA-IR is associated with endothelial dysfunction and confers independent prognostic information in non-diabetic patients with chest pain without myocardial perfusion defects. Increased systemic pro-inflammatory state and decreased levels of pro-angiogenic vascular growth factors may be important underlying molecular mechanisms.

Indexed as

Insulin ResistanceAgedAngina PectorisAngiogenic ProteinsBiomarkersChi-Square DistributionCoronary Artery DiseaseDisease-Free SurvivalEndothelium, VascularFemaleGene Expression RegulationHumansHyperemiaInflammation MediatorsLinear ModelsMaleAngiogenic ProteinsBiomarkersInflammation Mediators

Identifiers

PMID26892461
PMCPMC4759743
OpenAlexW2287995950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.